References
- Chanarin I. Cobalamins and nitrous oxide: a review. J Clin Pathol. 1980;33(10):909–916.
- Pema PJ, Horak HA, Wyatt RH. Myelopathy caused by nitrous oxide toxicity. AJNR Am J Neuroradiol. 1998;19(5):894–896.
- Thompson AG, Leite MI, Lunn MP, et al. Whippits, nitrous oxide and the dangers of legal highs. Pract Neurol. 2015;15(3):207–209.
- Jevtović-Todorović V, Todorovć SM, Mennerick S, et al. Nitrous oxide (laughing gas) is an NMDA antagonist, neuroprotectant and neurotoxin. Nat Med. 1998;4(4):460–463.
- Fujinaga M, Maze M. Neurobiology of nitrous oxide-induced antinociceptive effects. Mol Neurobiol. 2002;25(2):167–190.
- Sanders RD, Weimann J, Maze M. Biologic effects of nitrous oxide: a mechanistic and toxicologic review. Anesthesiology. 2008;109(4):707–722.
- Cao J, Xu S, Liu C. Is serum vitamin B12 decrease a necessity for the diagnosis of subacute combined degeneration? Medicine. 2020;99(14):e19700.
- Lindenbaum J, Savage DG, Stabler SP, et al. Diagnosis of cobalamin deficiency: II. Relative sensitivities of serum cobalamin, methylmalonic acid, and total homocysteine concentrations. Am J Hematol. 1990;34(2):99–107.
- Snow CF. Laboratory diagnosis of vitamin B12 and folate deficiency. Arch Intern Med. 1999;159(12):1289.
- Stabler SP. Clinical practice. Vitamin B12 deficiency. N Engl J Med. 2013;368(2):149–160.
- Hvas AM, Nexo E. Diagnosis and treatment of vitamin B12 deficiency-an update. Haematologica. 2006;91(11):1506–1512.
- Kamath A, Pemminati S. Methylcobalamin in vitamin B12 deficiency: to give or not to give? J Pharmacol Pharmacother. 2017;8(1):33–34.
- Stacy CB, Di Rocco A, Gould RJ. Methionine in the treatment of nitrous-oxide-induced neuropathy and myeloneuropathy. J Neurol. 1992;239(7):401–403.